UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Journal for immunotherapy of cancer, 2018-06, Vol.6 (1), p.61-12, Article 61

2018

Volltextzugriff (PDF)

Phase I study evaluating high dose ADXS11-001 treatment in women with carcinoma of the cervix

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS3096-TPS3096

2015

Volltextzugriff (PDF)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 in patients with recurrent advanced solid tumors

Journal for immunotherapy of cancer, 2018-06, Vol.6 (1)

2018

Volltextzugriff (PDF)

Acute Myelogenous Leukemia Patients Are at Low Risk for Invasive Fungal Infections after High-Dose Cytarabine Consolidations and Thus Do Not Require Prophylaxis

Acta haematologica, 2010-01, Vol.124 (4), p.206-213

2010

Volltextzugriff (PDF)

A Phase I study of NLG919 for adult patients with recurrent advanced solid tumors

Journal for immunotherapy of cancer, 2014-11, Vol.2 (Suppl 3), p.P250-P250

2014

Volltextzugriff (PDF)

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

Diabetes care, 2012-11, Vol.35 (11), p.2198-2200

2012

Volltextzugriff (PDF)

A multisystem, cardio-renal investigation of post-COVID-19 illness

Nature medicine, 2022-06, Vol.28 (6), p.1303-1313

2022

Volltextzugriff (PDF)

A combined first principles computational and solid-state NMR study of a molecular crystal: flurbiprofen

Physical chemistry chemical physics : PCCP, 2005-04, Vol.7 (7), p.1402-1407

2005

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment

Drug metabolism and disposition, 2015-07, Vol.43 (7), p.1077-1083

2015

Volltextzugriff (PDF)

Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies

Drug metabolism and disposition, 2012-11, Vol.40 (11), p.2090

2012

Volltextzugriff (PDF)

Service user and carer involvement in learning and teaching: A faculty of health staff perspective

Nurse education today, 2010-08, Vol.30 (6), p.509-514

2010

Volltextzugriff (PDF)

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

BMC pharmacology & toxicology, 2021-06, Vol.22 (1), p.34-34, Article 34

2021

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus

Journal of clinical pharmacology, 2010-06, Vol.50 (6), p.623-635

2010

Volltextzugriff (PDF)

Multiple-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double-Blind Study

Journal of clinical pharmacology, 2010-06, Vol.50 (6), p.636-646

2010

Volltextzugriff (PDF)

First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus

BMC pharmacology & toxicology, 2013-05, Vol.14 (1), p.26-26, Article 26

2013

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus

BMC pharmacology & toxicology, 2013-04, Vol.14 (1), p.25-25, Article 25

2013

Volltextzugriff (PDF)

Searching for evidence in public health emergencies: a white paper of best practices

Journal of the Medical Library Association, 2023-01, Vol.111 (1-2), p.566-578

2023

Volltextzugriff (PDF)

The Effect of Donor Age on Corneal Transplantation Outcome : Results of the Cornea Donor Study

Ophthalmology (Rochester, Minn.), 2008-04, Vol.115 (4), p.620-626

2008

Volltextzugriff (PDF)

Knowledge translation interventions for facilitating evidence‐informed decision‐making amongst health policymakers

Cochrane database of systematic reviews, 2022-10, Vol.2022 (10)

2022

Volltextzugriff (PDF)

Post-COVID-19 illness and associations with sex and gender

BMC cardiovascular disorders, 2023-08, Vol.23 (1), p.389-389, Article 389

2023

Volltextzugriff (PDF)

EBRNetwork – a call to action for evidence-based research

Trials, 2015-11, Vol.16 (S3), p.P10-P10, Article P10

2015

Volltextzugriff (PDF)

Regional gastrointestinal delivery of remogliflozin etabonate in humans

Biopharmaceutics & drug disposition, 2013-03, Vol.34 (2), p.79-86

2013

Volltextzugriff (PDF)

The Effect of ABO Blood Incompatibility on Corneal Transplant Failure in Conditions with Low-risk of Graft Rejection

American journal of ophthalmology, 2009-03, Vol.147 (3), p.432-438.e3

2009

Volltextzugriff (PDF)

Living with fair use and TEACH: a quest for compliance

Computers, informatics, nursing, 2005-05, Vol.23 (3), p.120

2005

Volltextzugriff (PDF)

The Sanctuary of Artemis Brauronia on the Athenian Akropolis

Hesperia, 1979-10, Vol.48 (4), p.325-341

1979

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(18)
Life Sciences & Biomedicine
(17)
Male
(15)
Female
(14)
Middle Aged
(14)
Adult
(12)
Glucosides - Pharmacokinetics
(8)
Pharmacology & Pharmacy
(8)
Pharmacokinetics
(7)
Glucose
(6)
Glucosides - Administration & Dosage
(6)
Pyrazoles - Pharmacokinetics
(6)
Diabetes
(5)
Hypoglycemic Agents - Administration & Dosage
(5)
Hypoglycemic Agents - Pharmacokinetics
(5)
Pharmacodynamics
(5)
Type 2 Diabetes Mellitus
(5)
Aged
(4)
Area Under Curve
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Phase I study evaluating high dose ADXS11-001 treatment in women with carcinoma of the cervix

Phase Ia study of the indoleamine 2,3-dioxygenase 1 in patients with recurrent advanced solid tumors

Acute Myelogenous Leukemia Patients Are at Low Risk for Invasive Fungal Infections after High-Dose Cytarabine Consolidations and Thus Do Not Require Prophylaxis

A Phase I study of NLG919 for adult patients with recurrent advanced solid tumors

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

A multisystem, cardio-renal investigation of post-COVID-19 illness

A combined first principles computational and solid-state NMR study of a molecular crystal: flurbiprofen

Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment

Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies

Service user and carer involvement in learning and teaching: A faculty of health staff perspective

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

Single-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus

Multiple-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double-Blind Study

First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus

Searching for evidence in public health emergencies: a white paper of best practices

The Effect of Donor Age on Corneal Transplantation Outcome : Results of the Cornea Donor Study

Knowledge translation interventions for facilitating evidence‐informed decision‐making amongst health policymakers

Post-COVID-19 illness and associations with sex and gender

EBRNetwork – a call to action for evidence-based research

Regional gastrointestinal delivery of remogliflozin etabonate in humans

The Effect of ABO Blood Incompatibility on Corneal Transplant Failure in Conditions with Low-risk of Graft Rejection

Living with fair use and TEACH: a quest for compliance

The Sanctuary of Artemis Brauronia on the Athenian Akropolis

Suchergebnisse filtern